Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaga Regulatory News (SAGA)

Share Price Information for Saga (SAGA)

Share Price is delayed by 15 minutes
Get Live Data
591.00    12.00 (2.07%)
Bid:
589.00
Ask:
590.00
Spread: 1.00 (0.17%)
Market Cap: £859.26m
SAGA Live PriceLast checked at - London Stock Exchange

Intraday Saga Share Chart

Directorate Change

9 Apr 2025 07:01

RNS Number : 2121E
SAGA PLC
09 April 2025
 

9 April 2025

Saga plc

Board changes

The Board of Saga announces that Sir Peter Bazalgette, Senior Independent Director, and Steve Kingshott, Executive Director, are stepping down from the Board with effect from today. These changes to the Board follow Saga's successful Insurance agreement with wholly owned UK subsidiaries of Ageas SA/NV, and reflect the Group's new simplified business model.

Sir Peter, who chairs the Nomination Committee, is also a member of the Remuneration Committee. The Company announces that Gareth Hoskin will become Senior Independent Director, Chair of the Nomination Committee and a member of the Remuneration Committee. Julie Hopes will become a member of the Nomination Committee. These changes take effect from 9 April 2025.

Sir Roger De Haan, Non-Executive Chairman of Saga, said:

"I would like to thank Sir Peter and Steve for all their hard work over the past years and the significant contributions they have each made. Their expertise in their respective fields of media and insurance have proven invaluable as we have reshaped Saga, positioning it for growth. We wish them well in their future endeavours."

Following the changes above, the membership of the Nomination and Remuneration Committees will be as follows:

Nomination Committee:

Gareth Hoskin (Chair), Anand Aithal. Sir Roger De Haan, Gemma Godfrey and Julie Hopes

 

Remuneration Committee:

Julie Hopes (Chair), Gemma Godfrey and Gareth Hoskin

 

There are no changes to the Audit, Innovation and Enterprise or Risk Committees.

 

 

For further information, please contact: 

Saga plc

3 Pancras SquareLondonN1C 4AG

 

Vicki Haynes, Company Secretary

Tel: 07803 602 139

Email: company.secretary@saga.co.uk

 

Emily Roalfe, Director of Investor Relations and Treasury

Tel: 07732 093 007

Email: emily.roalfe@saga.co.uk

 

Headland Consultancy

Susanna Voyle

Will Smith

Tel: 020 3805 4822

Tel: 07980 894 557

Tel: 07872 350 425

Email: saga@headlandconsultancy.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABCGDSSUGDGUI
Date   Source Headline
5th Jun 20241:40 pmRNSHolding(s) in Company
5th Jun 20241:34 pmRNSDirector Declaration
29th May 20244:29 pmRNSDirector/PDMR Shareholding
21st May 20249:00 amRNSNotice of AGM
13th May 202410:08 amRNSRepayment of Bond
7th May 20244:32 pmRNSTotal Voting Rights
30th Apr 20249:15 amRNSIssue of Equity
17th Apr 20247:00 amRNSPreliminary Results
30th Jan 20247:00 amRNSTrading Update
26th Jan 20247:00 amRNSResponse to Media Coverage
15th Jan 20244:52 pmRNSHolding(s) in Company
21st Dec 20234:43 pmRNSHolding(s) in Company
21st Dec 20234:39 pmRNSDirector/PDMR Shareholding
21st Dec 20233:44 pmRNSDirectorate Change
8th Dec 202312:53 pmRNSHolding(s) in Company
28th Nov 20237:00 amRNSDirectorate Change
20th Nov 20234:00 pmRNSHolding(s) in Company
2nd Nov 20232:44 pmRNSDirector/PDMR Shareholding
17th Oct 202311:53 amRNSHolding(s) in Company
9th Oct 20237:00 amRNSDirectorate Change
27th Sep 20237:01 amRNSDirectorate Change
27th Sep 20237:00 amRNSInterim Results
9th Aug 20234:47 pmRNSDirector/PDMR Shareholding
9th Aug 20234:44 pmRNSTotal Voting Rights
1st Aug 20233:03 pmRNSIssue of Equity
26th Jul 20238:37 amRNSChange of Registered Office
22nd Jun 20232:38 pmRNSHolding(s) in Company
20th Jun 20233:53 pmRNSResults of 2023 Annual General Meeting
20th Jun 20237:00 amRNSAGM Trading Update
13th Jun 20235:00 pmRNSDirector/PDMR Shareholding
30th May 20232:19 pmRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSNotice of AGM
18th Apr 20237:00 amRNSAnnual Report and Accounts and Strategic Report
4th Apr 20237:00 amRNSPreliminary Results
2nd Mar 20239:10 amRNSTermination of discussions with Open Insurance
10th Feb 20237:00 amRNSResponse to Media Coverage
24th Jan 20237:01 amRNSCapital Markets Event
24th Jan 20237:00 amRNSTrading Update
23rd Jan 20237:00 amRNSResponse to Media Coverage
28th Dec 20227:00 amRNSHolding(s) in Company
14th Dec 20227:00 amRNSDirectorate Change
17th Nov 20222:47 pmRNSHolding(s) in Company
17th Nov 20229:00 amRNSEstablishment of New Committee
18th Oct 202210:15 amRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSDirector/PDMR Shareholding
27th Sep 20227:00 amRNSInterim Results
23rd Aug 20227:00 amRNSDirectorate Change
18th Jul 20225:08 pmRNSDirector/PDMR Shareholding
8th Jul 202210:50 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.